A table on the perioperative care of people with diabetes in the abridged version of section 16 of the American Diabetes Association’s Standards of Care in Diabetes—2024 contained typographical errors. The corrected version is as follows.

The online version of this article (https://doi.org/10.2337/cd24-a016) has been updated to reflect this change.

Perioperative Care

A1C and glucose goals 
  • Elective surgery A1C goal: <8% (63.9 mmol/L)

  • Blood glucose goal within 4 hours of surgery: 100–180 mg/dL (5.6–10.0 mmol/L)

 
Medication adjustments 
  • Hold metformin on the day of surgery.

  • Discontinue sodium–glucose cotransporter 2 inhibitors 3–4 days before surgery.

  • Hold other oral glucose-lowering agents the morning of the surgery or procedure.

  • There are few data on the safe use and/or influence of glucagon-like peptide 1 receptor agonists on glycemia and delayed gastric emptying in the perioperative period.

  • Individualize plan based on clinical scenario and procedure/surgery.

 
Insulin therapy adjustments 
  • Give half of NPH dose or 75–80% of long-acting analog insulin or adjust insulin pump basal rates based on diabetes type and clinical judgment.

 
A1C and glucose goals 
  • Elective surgery A1C goal: <8% (63.9 mmol/L)

  • Blood glucose goal within 4 hours of surgery: 100–180 mg/dL (5.6–10.0 mmol/L)

 
Medication adjustments 
  • Hold metformin on the day of surgery.

  • Discontinue sodium–glucose cotransporter 2 inhibitors 3–4 days before surgery.

  • Hold other oral glucose-lowering agents the morning of the surgery or procedure.

  • There are few data on the safe use and/or influence of glucagon-like peptide 1 receptor agonists on glycemia and delayed gastric emptying in the perioperative period.

  • Individualize plan based on clinical scenario and procedure/surgery.

 
Insulin therapy adjustments 
  • Give half of NPH dose or 75–80% of long-acting analog insulin or adjust insulin pump basal rates based on diabetes type and clinical judgment.

 

This content is only available via PDF.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license.